Provided by Tiger Trade Technology Pte. Ltd.

RACE ONCOLOGY LTD

2.420
-0.030-1.22%
Volume:94.15K
Turnover:228.65K
Market Cap:437.50M
PE:-87.05
High:2.470
Open:2.410
Low:2.380
Close:2.450
52wk High:4.900
52wk Low:0.920
Shares:180.79M
Float Shares:121.21M
Volume Ratio:1.48
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.028
EPS(LYR):-0.028
ROE:-27.89%
ROA:-15.63%
PB:27.32
PE(LYR):-87.16

Loading ...

Company Profile

Company Name:
RACE ONCOLOGY LTD
Exchange:
ASX
Establishment Date:
2011
Employees:
- -
Office Location:
Gateway, 1 Macquarie Place,Level 36,Sydney,New South Wales,Australia
Zip Code:
2000
Fax:
- -
Introduction:
Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Melbourne, Australia.